Alimera sciences announces first quarter 2021 financial results

Atlanta, april 28, 2021 (globe newswire) -- alimera sciences, inc. (nasdaq: alim) (alimera), a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals for the treatment of retinal diseases, today announced financial results for the first quarter of 2021. alimera will host a conference call on april 29, 2021, at 9:00 a.m. et to discuss these results.
ALIM Ratings Summary
ALIM Quant Ranking